15.01.2020

Jonathan Tooth

Jonathan has over 25 years professional experience in corporate finance and public markets with a core expertise in ECM and M&A, primarily servicing small to mid-market companies.

Jonathan has broad experience with particularly strong sector expertise within FMCG, financial services and technology.

Jonathan has been involved in over 20 IPOs, ECM transactions that have collectively raised in excess of $2.5B, and M&A transactions with a combined enterprise value exceeding $2B. These included the Healthscope acquisition of Nova Health and ABC Learning Centres acquisition of Hutchison Child Care

Recent notable transactions include:

  • Advised Sensera (ASX:SE1) on its pre-IPO raising and IPO. As a Director led the acquisition of nanotron Technolgies GMBH
  • Advised Hemideina on three private capital raisings
  • Advised Watermark on its divestment to Xenith IP Group (ASX:XIP)

Previously Jonathan was a Director and the Head of Corporate Finance at Austock Group, a role he held for over 10 years. Before this, Jonathan worked in the corporate departments of two other brokerage firms in Melbourne and Perth and with an international firm’s corporate planning and development arm.

Jonathan is currently a Non-Executive Director of two ASX-listed companies – Generation Development Group (ASX:GDG) and Sensera Ltd (ASX:SE1).  He is also a Director of Hemideina. Jonathan is also a member (Chair of the investment committee) of the Melbourne Angels, an early-stage investor group focused on high-growth Australian businesses. Jonathan is an avid ice hockey player and spends his weekends managing a small farm in country Victoria.

Recent posts

Looking for investment opportunities?

Backed and vetted by Henslow, unlock a selection of unique investment opportunities. Register an account to get started.

Investment hub